Form 4: National Healthcare Corp Executive Ussery Receives Stock Options and Restricted Shares
SEC Form 4
Robert Michael Ussery, President & COO of National Healthcare Corp, reports the acquisition of stock options and restricted shares.
Summary
- Robert Michael Ussery, the President & COO of National Healthcare Corp, filed a Form 4.
- The filing indicates Ussery acquired 2,683 shares of common stock on March 5, 2025, at $0, bringing his total holdings to 155,721 shares.
- Ussery also acquired options to purchase common stock at various exercise prices and expiration dates.
- These include options for 4,234 shares at $63.96 expiring on February 18, 2027, 9,000 shares at $53.94 expiring on March 8, 2028, 13,500 shares at $94.1 expiring on March 5, 2029, and 15,000 shares at $90.62 expiring on February 24, 2030.
- The 2,683 restricted shares vest in three equal installments on January 1, 2026, January 1, 2027, and January 1, 2028.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options and restricted shares is a common practice and generally viewed as a positive incentive for executives.
Positives
- The grant of restricted shares and stock options to a key executive aligns their interests with those of the shareholders.
- The vesting schedule of the restricted shares encourages long-term commitment from the executive.
Industry Context
Executive compensation practices in the healthcare industry often include stock options and restricted shares to incentivize performance and align executive interests with shareholder value.
Comparison to Industry Standards
- Comparing the option grants to similar healthcare companies like Brookdale Senior Living or Life Care Centers of America would provide context on whether the size and terms of the grants are in line with industry norms.
- Benchmarking the vesting schedule against industry standards would also be beneficial.
Stakeholder Impact
- Shareholders may view the stock option and restricted share grants as a positive incentive for the executive team.
- Employees may see this as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date exercisable for options to purchase 4,234 shares at $63.96 expiring on 02/18/2027 |
| 03/08/2024 | Date exercisable for options to purchase 9,000 shares at $53.94 expiring on 03/08/2028 |
| 01/01/2026 | First vesting date (33 1/3%) for 2,683 restricted shares |
| 02/24/2026 | Date exercisable for options to purchase 15,000 shares at $90.62 expiring on 02/24/2030 |
| 01/01/2027 | Second vesting date (33 1/3%) for 2,683 restricted shares |
| 02/18/2027 | Expiration date for options to purchase 4,234 shares at $63.96 |
| 01/01/2028 | Final vesting date (33 1/3%) for 2,683 restricted shares |
| 03/08/2028 | Expiration date for options to purchase 9,000 shares at $53.94 |
| 03/05/2029 | Expiration date for options to purchase 13,500 shares at $94.1 |
| 02/24/2030 | Expiration date for options to purchase 15,000 shares at $90.62 |
| 03/05/2025 | Date of transaction: Grant of restricted shares and stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.